Hepatocellular carcinoma
Conditions
Interventions
Participants in Hepatocellular Carcinoma Surveillance:None
Participants with Other Malignant Tumors:None
Sponsors
Southern Medical University Southern Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Subjects for Liver Cancer Surveillance:; 1.1 Patients with cirrhosis due to various liver diseases attending hospitals: Voluntarily sign the informed consent form; Aged 18 years or above, regardless of gender; Diagnosed with cirrhosis; aMAP liver cancer risk score > 50 at enrollment. 1.2 Individuals at intermediate to high risk for liver cancer identified through community screening: Voluntarily sign the informed consent form; Male residents aged 35–64 years and female residents aged 45–64 years; Positive for hepatitis B surface antigen (HBsAg) in community serological testing; aMAP liver cancer risk score > 50 at enrollment. 2. Subjects with Other Malignancies Attending Hospitals: Voluntarily sign the informed consent form; Aged 18 years or above, regardless of gender; Diagnosed with malignancies other than hepatocellular carcinoma (HCC), with an expected survival period of more than 6 months; Have not received any systemic antitumor therapy (such as chemotherapy, targeted therapy, immunotherapy, etc.) for the malignancy at the time of enrollment.
Exclusion criteria
Exclusion criteria: 1.History of liver cancer, liver transplantation, or co-infection with hepatitis C or human immunodeficiency virus (HIV); 2.Pregnancy; 3.Deemed by the investigator as ineligible to participate in the study;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Detection Rate of Primary Hepatocellular Carcinoma (HCC);Early-Stage (BCLC Stage 0 and A) Primary Hepatocellular Carcinoma Detection Rate;True Positive Rate and False Positive Rate; | — |
Countries
China
Contacts
Public ContactJinlin Hou
Southern Medical University Southern Hospital
Outcome results
None listed